Results
From November 2022 to February 2023, our test was conducted in accordance with the intention-to-treat method. Forty patients were eligible for enrolment and agreed to participate, and no patient was excluded (see Fig. 
Patient characteristics and clinical data presented as the mean ± standard deviation or percentages as appropriate